Apple watch Hypertension Detection Feature Cleared by FDA, Launching Next Week
Apple has announced that its anticipated hypertension detection feature for the Apple Watch will become available next week, following official clearance from the U.S. Food and Drug Management (FDA) on Thursday. This new health monitoring capability was initially unveiled during Apple’s product launch event in early September.
The feature will roll out across 150 countries and regions, including the United States, Hong Kong, and member states of the European Union. Apple previously indicated that the feature’s release was contingent upon receiving regulatory approvals from the FDA and international bodies.
The hypertension detection feature utilizes the apple Watch’s existing heart rate sensor to passively monitor users for signs of high blood pressure. While details regarding the specific algorithms and data analysis methods remain proprietary, the technology aims to provide users with greater awareness of their cardiovascular health and encourage proactive management of hypertension. Users should not rely on the Apple Watch to replace regular checkups with their healthcare provider.